Trials / Completed
CompletedNCT01077817
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
The Risk of Esophageal Cancer in Relation to the Treatment and Prevention of Osteoporosis in Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 684,815 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
This is a 2-phase retrospective database study, using both case-cohort and inception (intention-to-treat) cohort analyses to evaluate any association between oral treatments for osteoporosis and the risk of esophageal cancer in women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alendronate | |
| DRUG | Etidronate | |
| DRUG | Ibandronate | |
| DRUG | Risedronate | |
| DRUG | Raloxifene |
Timeline
- Start date
- 2010-02-26
- Primary completion
- 2012-02-16
- Completion
- 2012-02-16
- First posted
- 2010-03-01
- Last updated
- 2022-02-03
- Results posted
- 2013-05-01
Source: ClinicalTrials.gov record NCT01077817. Inclusion in this directory is not an endorsement.